Inflammatory Pathways in Diabetes

Part 1. Introduction.- 1. Impact of inflammation and the innate immunity response in obesity mediated diabetes (lit review).- Part 2. Impact of complement on diabetic disease.- 2. Complement and Complement Regulatory Proteins in Diabetes.- Part 3. Role of C terminal fragment of adiponectin receptor in inhibition of insulin degradation.- 3. Development of adiponectin receptor C terminal fragment bioassays.- 4. Protease inhibition and biological distribution of the C terminal fragment of adiponectin receptor.- 5. Cell & biological models for the C terminal fragment of adiponectin receptor.- 6. C-Terminal fragment of adiponectin receptor clinical correlations.- Part 4. Uristatin assay for prediction of renal and other clinical events.- 7. Uristatin immunoassay usage in glomerular nephritis assessment.- 8. Acute Response of Uristatin in Surgery.- 9. Cardiovascular and metabolic syndrome impact on uristatin.- 10. Uristatin anti-inflammatory cellular signaling.- Part 5. Summary.- 11. Overview of progress in new markers for diabetes inflammation (Literatue Review).

Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.

• Farmacologia
• Diabetes
• Metabolismo
• Bioquímica

adiponectin receptor;biomarkers;diabetic diseases;diagnostic methods;inflammatory pathways;diabetes;metabolic disease